Shanghai, China

Zengquan Wang

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2018-2026.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Zengquan Wang: Innovator in Hair Growth Solutions

Introduction

Zengquan Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that promote hair growth. His innovative work has the potential to impact many individuals seeking solutions for hair loss.

Latest Patents

Wang holds a patent for a small molecule compound and its synthesizing method, which is designed to promote hair growth. The patent describes a small molecule compound represented by structural formula (I). The product has been shown to achieve noticeable changes in the growth period of hairs at various concentrations and dosages. Importantly, the test compound does not cause weight loss in animals, indicating its safety for use.

Career Highlights

Zengquan Wang is currently associated with Technoderma Medicines Pte Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to creating effective and safe solutions for hair growth.

Collaborations

Wang collaborates with talented individuals in his field, including Sheldon Cao and Chen Mao. These partnerships enhance the innovative capacity of his projects and contribute to the success of their shared goals.

Conclusion

Zengquan Wang is a pioneering inventor whose work in small molecule compounds offers promising advancements in hair growth solutions. His contributions to the field reflect a dedication to innovation and safety in medicinal chemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…